K-numberK251909
Device nameNeurotriS (SX2500); NeurotriS (SX3800)
ApplicantA-1 Engineering
Product codeNFO
Device classClass II
Decision dateSep 3, 2025
DecisionSubstantially Equivalent
Regulation882.5890
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The NeurotriS SX2500 and SX3800 are microcurrent electrical stimulation devices designed to deliver low electrical current to facial tissues for aesthetic purposes. They use various applicators such as probes, conductive gloves, and pads to deliver the stimulation through one to four independent output channels.

Technological characteristics

Both devices feature biphasic rectangular waveforms with regulated current and voltage output, software-controlled operation with automatic overload and no-load trip protection, 1–4 output channels delivering identical isolated signals, and maximum output parameters (voltage, current, frequency, and phase duration) substantially matching the predicate devices across multiple load impedances (500Ω, 2kΩ, 10kΩ).

Test standards cited

IEC 60601-1-2:2014 (with Amendment 1:2021), IEC 60601-1:2005 with corrections, IEC 60601-1-11:2015+A1, Edition 4.1 EMC (IEC 60601-1-2:2020), and ISO 10993-1:2018 (biocompatibility). Compliance with 21 CFR 989 was also demonstrated.

Substantial equivalence argument

The SX2500 and SX3800 are substantially equivalent because they share identical intended use (facial tissue stimulation for aesthetic purposes), the same waveform type and output characteristics as predicate devices TAMA (K173093) and Biosonic (K130065), and substantially equivalent applicators (probes, gloves, pads). Although the SX3800 offers up to 4 channels versus the predicate's 1–4 ports, all channels deliver identical isolated signals, and bench testing confirmed output parameters across all simultaneously-active channels match predicate performance. All technological parameters—including voltage, current, frequency, phase duration, net charge, and current density—demonstrated substantial equivalence in the detailed tabular comparison.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →